Finance

Lists
Why is OBIO down 3,21%?
Dive Deeper
OBIO:NASDAQ
Orchestra Biomed Holdings Inc
US$5,72
-3,21%
(-0,19) 1D
US$5,72
0,00% (0,00)
After hours
Closed: 13 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OBIO...
Open
US$5,87
High
US$5,87
Low
US$5,71
Mkt. cap
343,80 ລ້ານ
Avg. vol.
342,01 ພັນ
Volume
204,82 ພັນ
52-wk high
US$6,50
52-wk low
US$3,10
EPS
US$-1,01
Beta
0,52
Shares outstanding
60,10 ລ້ານ
No. of employees
86
Open
US$5,87
High
US$5,87
Low
US$5,71
Mkt. cap
343,80 ລ້ານ
Avg. vol.
342,01 ພັນ
Volume
204,82 ພັນ
52-wk high
US$6,50
52-wk low
US$3,10
EPS
US$-1,01
Beta
0,52
Shares outstanding
60,10 ລ້ານ
No. of employees
86
News stories
From web sources and news partners
About Orchestra Biomed Holdings Inc
CEO-
Employees86
Founded2018
Headquarters-
SectorMedical device
Analyst ratings
Based on 5 analysts giving stock ratings to OBIO in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for OBIO in the last 3 months.
Highest
Current US$5,72
US$15,00 (+162,24%)
Average
US$11,20 (+95,80%)
Lowest
US$10,00 (+74,83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$10,00
+74,8%
10/05/2026
Madison Elsaadi
B. Riley Securities
Buy
Reiterated
US$11,00
+92,3%
10/02/2026
Josh Jennings
TD Cowen
Buy
Reiterated
US$15,00
+162,2%
09/25/2026
Marie Thibault
BTIG
Buy
Upgraded
US$10,00
+74,8%
09/10/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
US$10,00
+74,8%
08/11/2026
Unknown Analyst
BTIG
Hold
Maintained
-
-
07/09/2026
Anderson Schock
B. Riley Securities
Buy
Reiterated
US$10,00
+74,8%
05/18/2026
Matt Miksic
Barclays
Buy
Reiterated
US$13,00
+127,3%
05/13/2026
Keay Nakae
Chardan Capital
Buy
Maintained
US$20,00
+249,7%
03/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
861,00 ພັນ
30,92 ລ້ານ
110,00 ພັນ
88,00 ພັນ
Cost of goods sold
49,00 ພັນ
51,00 ພັນ
32,00 ພັນ
25,00 ພັນ
Cost of revenue
49,00 ພັນ
51,00 ພັນ
32,00 ພັນ
25,00 ພັນ
Research and development expenses
14,03 ລ້ານ
16,82 ລ້ານ
15,78 ລ້ານ
16,59 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,10 ລ້ານ
7,29 ລ້ານ
6,37 ລ້ານ
5,83 ລ້ານ
Operating expense
21,12 ລ້ານ
24,11 ລ້ານ
22,15 ລ້ານ
22,42 ລ້ານ
Total operating expenses
21,17 ລ້ານ
24,16 ລ້ານ
22,19 ລ້ານ
22,44 ລ້ານ
Operating income
-20,31 ລ້ານ
6,75 ລ້ານ
-22,08 ລ້ານ
-22,36 ລ້ານ
Other non operating income
-
254,00 ພັນ
-376,00 ພັນ
-517,00 ພັນ
EBT including unusual items
-20,83 ລ້ານ
6,24 ລ້ານ
-20,69 ລ້ານ
-23,76 ລ້ານ
EBT excluding unusual items
-20,83 ລ້ານ
6,24 ລ້ານ
-22,93 ລ້ານ
-23,80 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20,83 ລ້ານ
6,24 ລ້ານ
-20,69 ລ້ານ
-23,76 ລ້ານ
Net profit margin
-2.419,05%
20,20%
-18.810,00%
-26.994,32%
Earnings per share
-0,40
0,26
-0,33
-0,37
Interest and investment income
-
752,00 ພັນ
-
-
Interest expense
-515,00 ພັນ
-1,52 ລ້ານ
-480,00 ພັນ
-927,00 ພັນ
Net interest expenses
-515,00 ພັນ
-763,00 ພັນ
-480,00 ພັນ
-927,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-20,23 ລ້ານ
6,84 ລ້ານ
-21,99 ລ້ານ
-22,26 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google